FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 140 filers reported holding FATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,461 | -36.3% | 81,821 | +43.1% | 0.00% | – |
| Q2 2023 | $272,253 | -7.4% | 57,196 | +10.8% | 0.00% | – |
| Q1 2023 | $294,154 | -8.8% | 51,606 | +61.5% | 0.00% | – |
| Q4 2022 | $322,487 | -55.0% | 31,961 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $716,246 | -12.3% | 31,961 | -3.1% | 0.00% | -50.0% |
| Q2 2022 | $817,000 | -82.1% | 32,989 | -71.9% | 0.00% | -77.8% |
| Q1 2022 | $4,559,000 | +144.5% | 117,595 | +269.1% | 0.01% | +125.0% |
| Q4 2021 | $1,865,000 | -86.9% | 31,862 | -86.7% | 0.00% | -85.7% |
| Q3 2021 | $14,217,000 | -21.7% | 239,875 | +14.6% | 0.03% | -20.0% |
| Q2 2021 | $18,164,000 | -7.7% | 209,287 | -12.3% | 0.04% | -12.5% |
| Q1 2021 | $19,685,000 | +7.5% | 238,747 | +18.6% | 0.04% | +8.1% |
| Q4 2020 | $18,306,000 | +1568.7% | 201,318 | +633.5% | 0.04% | +1750.0% |
| Q3 2020 | $1,097,000 | +47.4% | 27,448 | +26.6% | 0.00% | 0.0% |
| Q2 2020 | $744,000 | +11.0% | 21,686 | -28.1% | 0.00% | 0.0% |
| Q1 2020 | $670,000 | +15.9% | 30,174 | +2.2% | 0.00% | +100.0% |
| Q4 2019 | $578,000 | +71.0% | 29,519 | +35.8% | 0.00% | 0.0% |
| Q3 2019 | $338,000 | -31.9% | 21,740 | -11.0% | 0.00% | 0.0% |
| Q2 2019 | $496,000 | +12.5% | 24,438 | -2.7% | 0.00% | 0.0% |
| Q1 2019 | $441,000 | +37.0% | 25,112 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $322,000 | -3.0% | 25,112 | +23.4% | 0.00% | 0.0% |
| Q3 2018 | $332,000 | +43.7% | 20,350 | 0.0% | 0.00% | – |
| Q2 2018 | $231,000 | +16.1% | 20,350 | 0.0% | 0.00% | – |
| Q1 2018 | $199,000 | +50.8% | 20,350 | -5.5% | 0.00% | – |
| Q4 2017 | $132,000 | +55.3% | 21,533 | 0.0% | 0.00% | – |
| Q3 2017 | $85,000 | – | 21,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |